{
  "ticker": "VRTX",
  "year": 2023,
  "quarter": 2,
  "last_updated": "2025-04-15T14:01:53.509490",
  "count": 3,
  "transactions": [
    {
      "id": 42998,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 43024,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 43027,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    }
  ]
}